The board of directors of BRD SocGen, the fourth largest bank in Romania by assets, has convened the general meeting of shareholders on April 24, a date when they will vote, among other things, on the distribution of dividends in the amount of RON737.4 million, representing 50% of last year’s net profit of RON1.47 billion.
Romanian drug manufacturer Antibiotice Iasi has proposed the distribution of RON13.8 million worth of dividends from the 2024 net profit reported on the basis of annual audited financial statements, namely RON102.2 million.
Home ownership remains a major objective for most Romanians, but the increasingly dwindling affordability in central areas and strict lending conditions led to a decline in home buying intentions in 2025, stated Gabriel Blanita, Director & Advisory Services at Colliers Romania.